Age-Related Macular Degeneration

Age-Related Macular Degeneration

Author: Giuseppe Lo Giudice

Publisher: BoD – Books on Demand

Published: 2013-06-12

Total Pages: 203

ISBN-13: 9535111132

DOWNLOAD EBOOK

Age-related macular degeneration (AMD) is the leading cause of irreversible central vision loss in developed countries.There have been rapid developments of therapies that today can halt or even reverse aspects of vision loss resulting from AMD among those most severely affected, and there is promise of future therapies that may prevent vision loss. This book provides an overview about AMD; an update on the current understanding of AMD, pathophysiology, the use of diagnostic tests, the management of both non-neovascular and neovascular AMD as well as future directions in treatment and its limitations. It also looks into the future with potential treatment options that are now under investigation in clinical trials.


Age Related Macular Degeneration

Age Related Macular Degeneration

Author: Gui-Shuang Ying

Publisher: BoD – Books on Demand

Published: 2012-01-20

Total Pages: 314

ISBN-13: 9533078642

DOWNLOAD EBOOK

Age-related Macular Degeneration (AMD) is the leading cause of vision loss and blindness in the developed countries. In the past decade, great progress has been made in understanding the pathobiology and genetics of this blinding disease, as well as in finding new therapies for its treatment. These include the discovery of several genes that are associated with the risk of AMD, new anti-VEGF treatments for wet AMD and new imaging techniques to diagnose and monitor the AMD. All chapters in this book were contributed by outstanding research scientists and clinicians in the area of AMD. I hope this timely book will provide the basic scientists and clinicians with an opportunity to learn about the recent advances in the field of AMD.


Macular Degeneration

Macular Degeneration

Author: Michael Samuel

Publisher: ReadHowYouWant.com

Published: 2009-04-02

Total Pages: 234

ISBN-13: 1458701336

DOWNLOAD EBOOK

"In easy to understand language, ophthalmologist Michael Samuel, M.D., a renowned retinal specialist, casts the spotlight on this disease and offers a wealth of insights into what macular degeneration is, what causes it, and the array of contemporary treatment options."--Page 4 of cover.


Investigating Age-related Macular Degeneration

Investigating Age-related Macular Degeneration

Author: Jennifer C. Tournear

Publisher:

Published: 2018

Total Pages: 238

ISBN-13: 9780438392229

DOWNLOAD EBOOK

Age-related macular degeneration (AMD) is a retinal disease that can cause severe vision loss. It is responsible for the majority of blindness in developed countries in the elderly population. The disease is characteristically multifactorial where oxidative stress, inflammation and retinal lipofuscin (cellular waste product) accumulation have been indicated in disease progression. The retinal pigment epithelial (RPE) attaches to the Bruch's membrane (BM) and the symbiotic relationship between these two layers of the retina is essential for the visual cycle to function normally. Retinal lipofuscin is believed to contribute to drusen (characteristic deposits in the AMD BM) that negatively impact the BM and, in turn, the retina. Investigating the biological changes to the retina that are catalyzed by chemical reactions, such as photooxidation, can help to further the understanding of AMD. It is believed that when the BM is significantly modified, the RPE cells detach and undergo cell death. Retinal cell death is a hallmark of AMD. This work includes the investigation of ARPE-19 cell death when extracellular matrix (ECM) has been modified to model AMD through oxidative stress, aging and inflammation. Results indicate overlapping cell death pathways are activated as a result of ECM modification including proinflammatory cell death mechanisms: pyroptosis and necroptosis. Lipofuscin extracts obtained from human donor eyes where donors were previously diagnosed with one of three retinal diseases (wet AMD, dry AMD or diabetic retinopathy) are investigated using liquid chromatography mass spectrometry. Photooxidation products, inflammatory biomarkers and aging biomarkers are investigated as being components making up lipofuscin. Specifically, the observation of these components in association with a particular retinal disease is examined. Results indicate trends associated with oxidative stress markers being linked to wet AMD samples and inflammatory biomarkers being mostly associated with dry AMD samples. This work uses a two-prong approach to explore AMD onset and progression. Through the investigation of cell death using disease models and the components of lipofuscin buildup in human tissue, we begin to identify the impact and consequences these biological changes have on the retina.